Chemotherapy-Induced Peripheral Neuropathy: Association With Increased Risk of Falls and Injuries

Estelle Autissier

chemotherapy-induced peripheral neuropathy, functional impairment, falls
CJON 2019, 23(4), 405-410. DOI: 10.1188/19.CJON.405-410

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and degenerative side effect of many commonly used chemotherapy agents. Symptoms manifest as sensory and motor neuropathies. CIPN may necessitate chemotherapy dose reduction or discontinuation.

Objectives: This review intends to summarize literature linking CIPN to an increased risk of falls and injuries and provides recommendations to help maintain patient safety and maximize physical function.

Methods: A literature search was conducted using MEDLINE®, PubMed®, and ScienceDirect.

Findings: Assessment of CIPN and CIPN-related falls and injuries is vital in preventing related complications, and proper education of oncology nursing staff on CIPN assessment and management is necessary.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.